Mesa Laboratories Inc (MLAB)

NASD · Technology · Scientific & Technical Instruments · USA

Mesa Laboratories Inc is a small cap company (market value between $300 million and $2 billion) in the Scientific & Technical Instruments industry.

Mesa Laboratories designs and manufactures life sciences tools and quality control solutions for pharmaceutical, healthcare and medical device industries. The company operates four segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions, serving customers globally through direct sales and distributors.

From its FY2026 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Mesa Laboratories Inc stock.

Our verdict on MLAB

Overvalued: intrinsic value $44.35 per share, market price $134.60, margin of safety -203.5% (as of 2026-11-17).

Discounting its cash flows at 9.7% (average of 3 methods) values the shares at $44.35; the price of $134.60 is 204% above that value, and 74% of that value comes from beyond year five.

ETFs with the most weight in MLAB

17 more funds hold it; the full list is part of the paid plan.

More on MLAB

Browse

Peers in Scientific & Technical Instruments

All 32 Scientific & Technical Instruments stocks

Cheaper than MLAB in Scientific & Technical Instruments

10 more in this industry show a wider margin of safety.

Is MLAB undervalued or overvalued?

MLAB is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 9.7% (average of 3 methods) values the shares at $44.35; the price of $134.60 is 204% above that value, and 74% of that value comes from beyond year five.

What is the intrinsic value of MLAB?

$44.35 per share (as of the 2026-11-17 close), against a market price of $134.60. That is a margin of safety of -203.5%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.